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Neurons and glia are generated throughout adulthood from
proliferating cells in two regions of the rat brain, the subven-
tricular zone (SVZ) and the hippocampus. This study shows that
exogenous basic fibroblast growth factor (FGF-2) and epider-
mal growth factor (EGF) have differential and site-specific ef-
fects on progenitor cells in vivo. Both growth factors expanded
the SVZ progenitor population after 2 weeks of intracerebro-
ventricular administration, but only FGF-2 induced an increase
in the number of newborn cells, most prominently neurons, in
the olfactory bulb, the normal destination for neuronal progen-
itors migrating from the SVZ. EGF, on the other hand, reduced
the total number of newborn neurons reaching the olfactory
bulb and substantially enhanced the generation of astrocytes in
the olfactory bulb. Moreover, EGF increased the number of
newborn cells in the striatum either by migration of SVZ cells or
by stimulation of local progenitor cells. No evidence of neuronal
differentiation of newborn striatal cells was found by three-
dimensional confocal analysis, although many of these new-
born cells were associated closely with striatal neurons. The
proliferation of hippocampal progenitors was not affected by
either growth factor. However, EGF increased the number of
newborn glia and reduced the number of newborn neurons,
similar to the effects seen in the olfactory bulb. These findings
may be useful for elucidating the in vivo role of growth factors
in neurogenesis in the adult CNS and may aid development of
neuronal replacement strategies after brain damage.
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The adult CNS appears to have only limited potential to generate
new neurons, making it vulnerable to injury and disease. How-
ever, certain areas of the brain retain the capacity for neurogen-
esis well into adulthood (Altman and Das, 1965; Kuhn et al.,
1996). In the adult rodent a rapidly dividing population of stem
cells in the subventricular zone (SVZ) of the lateral ventricle
generates all neural cell types: neurons, astrocytes, and oligoden-
drocytes (Lewis, 1968; Privat and Leblond, 1972; Corotto et al.,
1993; Lois and Alvarez-Buylla, 1993; Morshead et al., 1994;
Goldman, 1995; Hauke et al., 1995). From the SVZ neuronal
progenitors migrate tangentially (sagittally) along the rostral mi-
gratory stream (RMS) into the olfactory bulb (OB), where they
differentiate into granule and periglomerular neurons (Corotto et
al., 1993; Lois and Alvarez-Buylla, 1993, 1994; Luskin, 1993;
Goldman, 1995; Lois et al., 1996). In contrast, glial progenitor
cells migrate radially into neighboring brain structures such as
striatum, corpus callosum, and neocortex (Levison and Goldman,
1993; Levison et al., 1993; Luskin and McDermott, 1994). In the
hippocampal dentate gyrus of adult rats, neural precursor cells
continue to proliferate and differentiate into granule cells
(Kaplan and Hinds, 1977; Kaplan and Bell, 1983; Cameron et al.,
1993; Kuhn et al., 1996).
To be able to manipulate the endogenous adult progenitors, we
believe it is crucial to determine the extracellular signals that can
stimulate cell division and regulate the fate of these neural stem
and progenitor cells (Cattaneo and McKay, 1991; Gage, 1994).
Recently, several groups successfully have isolated and propa-
gated adult neural progenitor cells in vitro (Reynolds and Weiss,
1992; Richards et al., 1992; Lois and Alvarez-Buylla, 1993;
Vescovi et al., 1993; Morshead et al., 1994; Gage et al., 1995a;
Palmer et al., 1995; Gritti et al., 1996). Dissociated cells from the
SVZ and the hippocampus required basic fibroblast growth factor
(FGF-2) or epidermal growth factor (EGF) for proliferation and
long-term survival in vitro. Some of these cells retain the ability to
generate both neurons and glia, suggesting that newborn cells of
the adult brain may originate from stem cell-like progenitors
(Morshead et al., 1994; Gage et al., 1995a; Palmer et al., 1995;
Gritti et al., 1996; Suhonen et al., 1996).
The possibility that growth factors also may influence neural
progenitors in vivo has been supported by findings that intrace-
rebroventricular administration of EGF expanded proliferative
progenitors in the SVZ of adult mice (Craig et al., 1996). Numer-
ous newborn cells were found in the adjacent striatum, septum,
and cortex, and a small portion of these cells expressed neuronal
antigens.
The goal of the present study was to explore systematically the
effects of FGF-2 or EGF on the proliferation and differentiation
of neural progenitor cells in the SVZ/OB system and the dentate
gyrus of adult rats. FGF-2, EGF, or artificial CSF (aCSF) were
chronically infused into the lateral ventricle. The proliferative
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zones, migratory paths, and areas of neuronal differentiation were
analyzed quantitatively for the number and phenotype of new-
born cells.
MATERIALS AND METHODS
Animals and surgery
Male Fischer-344 albino rats (n 5 30; Harlan Sprague Dawley, India-
napolis, IN) were used in this experiment. The animals were 13–14
weeks old and weighed between 260 and 300 gm at the start of the
experiment. Anesthesia was induced by an intramuscular injection con-
sisting of 62.5 mg/kg ketamine (Ketaset, 100 mg/ml, Bristol Laborato-
ries, Syracuse, NY), 3.175 mg/kg xylazine (Rompun, 20 mg/ml, Miles
Laboratories, Shawnee, KS), and 0.625 mg/kg acepromazine maleate
(10 mg/ml, TechAmerica Group, Elwood, KS) dissolved in 0.9% sterile
saline. Rats were mounted in a small animal stereotaxic apparatus
(David Kopf, Tujunga, CA) with bregma and lambda in the same
horizontal plane. A stainless steel cannula (28 gauge, Plastic Products,
Roanoke, VA) was implanted in the lateral ventricle [anteroposterior
(AP) 18.5 mm, lateral 11.5 mm from the center of the interaural line in
flat skull position; cannula length, 5 mm] and connected by 3.5 cm vinyl
tubing (size V/4, Bolab, Lake Havasu City, AZ) to an osmotic minipump
(model 2002, Alza, Palo Alto, CA). Human recombinant EGF (30 mg/ml,
Promega, Madison, WI) or FGF-2 (30 mg/ml, A. Baird, Prizm Pharma-
ceuticals, San Diego, CA) was dissolved in aCSF [(in mM): 148 NaCl, 3
KCl, 1.4 CaCl2 , 0.8 MgCl2 , 1.5 Na2HPO4 , and 0.2 NaH2PO4 , pH 7.4]
containing 100 mg/ml rat serum albumin (Sigma, St. Louis, MO). An
antibiotic (gentamycin, 50 mg/ml, Sigma) was included in the infusate.
The animals received EGF (n 5 10), FGF-2 (n 5 10), or aCSF (n 5 10)
at a flow rate of 0.50 ml /hr, resulting in a delivery of 360 ng of growth
factor per day for 14 d. During the last 12 d of the pump period animals
received daily intraperitoneal injections of bromodeoxyuridine (BrdU,
50 mg/kg, Sigma). At the end of the treatment one-half of the animals
(n 5 5 per group) were anesthetized deeply and perfused intracardially
with 4% paraformaldehyde in 100 mM phosphate buffer, pH 7.4. Brains
were removed, post-fixed overnight in 4% paraformaldehyde, and trans-
ferred to 0.32 M sucrose. In the remaining one-half of the animals the
pumps were removed under methoxyflurane anesthesia. The vinyl tubing
was ligated with sterile nonabsorbable black monofilament nylon (3–0
Dermalon, American Cyanamid, Danbury, CT). These animals were
perfused after an additional 4 week period without growth factor
infusion.
Histology
The brains were cut in three parts, providing material for (1) coronal
sections of the SVZ and hippocampus and sagittal sections of the (2) OB
and (3) cerebellum. Sections (40 mm) were cut with a sliding microtome
and stored at 220°C in a cryoprotectant solution (glycerol, ethylene
glycol, and 0.1 M phosphate buffer, pH 7.4, 3:3:4 by volume).
Antibodies and immunochemicals. The following antibodies and final
dilutions were used: mouse (mo) a-BrdU (1:400, Boehringer Mannheim,
Indianapolis, IN), rat a-BrdU (1:100, Accurate, Westbury, NY), mo
a-PSA-NCAM (1:2500, clone MenB kindly provided by Dr. G. Rougon,
University of Marseille, Marseille, France), mo a-NeuN (1:20, clone A60
kindly provided by Dr. R. Mullen, University of Utah, Salt Lake City,
UT), rabbit a-S100b (1:5000, Swant, Bellinzona, Switzerland), biotiny-
lated horse a-mouse IgG (1:160, Vector Laboratories, Burlingame, CA),
avidin–biotin–peroxidase complex (1:100, Vectastain Elite, Vector Lab-
oratories), and donkey a-rat–FITC, a-mouse–Texas Red, and a-rabbit–
CY5 (all 1:300, Jackson ImmunoResearch, West Grove, PA).
Immunoperoxidase. Free-floating sections were treated with 0.6%
H2O2 in TBS (0.15 M NaCl and 0.1 M Tris-HCl, pH 7.5) for 30 min to
block endogenous peroxidase. For DNA denaturation, sections were
incubated for 2 hr in 50% formamide/23 SSC (0.3 M NaCl and 0.03 M
sodium citrate) at 65°C, rinsed for 5 min in 23 SSC, incubated for 30 min
in 2N HCl at 37°C, and rinsed for 10 min in 0.1 M boric acid, pH 8.5.
Several rinses in TBS were followed by incubation in TBS/0.1% Triton
X-100/3% normal horse serum (TBS–Ths) for 30 min and incubation
with mo a-BrdU antibody in TBS–Ths overnight at 14°C. After being
rinsed in TBS–Ths, sections were incubated for 1 hr with biotinylated
horse a-mouse antibody. With intermittent rinses in TBS, avidin–biotin–
peroxidase complex was applied for 1 hr, followed by peroxidase detec-
tion for 5 min (0.25 mg/ml DAB, 0.01% H2O2 , 0.04% NiCl).
Immunofluorescence. Sections were treated for DNA denaturation as
described above, followed by several rinses in TBS and incubation in
TBS/0.1% Triton X-100/3% normal donkey serum (TBS–Tds) for 30
min. Primary antibodies were applied in TBS–Tds for 48 hr at 14°C,
rinsed in TBS three times for 10 min, and blocked in TBS–Tds for 10
min. Antibodies were detected with donkey a-rat, mouse, or rabbit
coupled to FITC, Texas Red, or CY5 for 2 hr. Fluorescent signals were
detected and processed by a confocal scanning laser microscope (Bio-
Rad MRC1024, Hercules, CA) and Adobe Photoshop (Adobe Systems,
Mountainview, CA).
Quantification
Quantification of BrdU-positive cells was accomplished with unbiased
counting methods. The optical disector procedure (Sterio, 1984) was
used to determine the three-dimensional numerical density of BrdU-
positive cells, which is expressed as cells/mm 3. Structures were sampled
either by selecting predetermined areas on each section (Fig. 1; SVZ,
striatum, RMS, and OB) or by analyzing entire structures on each section
(dentate gyrus and cerebellum). In the latter case we used a point-
counting grid for determination of the sampling volume via the Cavalieri
method (Michel and Cruz-Orive, 1988).
Lateral ventricle and striatum. Every 12th section from a coronal series
of the striatum was selected between AP 110.6 mm—genu corpus
callosum—and AP 18.74 mm—anterior commissure crossing (Paxinos
and Watson, 1986). As illustrated in Figure 1 B, BrdU-positive cells were
counted in three predetermined areas (50 3 50 mm) of the lateral
ventricle wall on all selected sections. A rectangular area of the striatum
(300 3 600 mm) was selected at a 50 mm distance from the lateral
ventricle wall and analyzed on each section. All BrdU-positive nuclei in
these selected areas were counted and presented as the number of cells
(in thousands)/mm 3 (Table 1).
RMS and OB. Every sixth section (40 mm) from sagittal series of the
OB/frontal cortex was selected and stained for BrdU immunohistochem-
Figure 1. Analysis of the subventricular zone (SVZ) and olfactory bulb.
A, Sagittal view of the rat brain illustrating the anatomical sites of
progenitor proliferation in the SVZ, migration along the rostral migratory
stream (RMS), and differentiation in the olfactory bulb (OB). Hatched bar
indicates position of coronal view in B. B, Coronal plane of the lateral
ventricle with the corpus callosum (CC), medial septum (MS), and stria-
tum (Str). Three areas in the SVZ (ventral, lateral, and dorsal squares,
50 3 50 mm) and one area in the striatum (large rectangle, 300 3 600 mm)
were analyzed for BrdU-positive cells on each section. C, Parasagittal
plane of frontal cortex and olfactory bulb. Two areas of the RMS (small
squares, 50 3 50 mm) and four areas of the OB granule cell layer (large
squares, 100 3 100 mm) were analyzed for BrdU-positive cells and
colabeling with NeuN or S100b.
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istry. As depicted in Figure 1C, two predetermined areas (50 3 50 mm)
in the RMS and four areas (100 3 100 mm) in the granule cell layer
(GCL) of the OB were analyzed on each section. All BrdU-positive
nuclei in these selected areas were counted and presented as the number
of cells (in thousands)/mm 3 (Table 1).
Dentate gyrus. Every 12th section (40 mm) from a coronal series was
selected from each animal and processed for immunoperoxidase. Six
sections from the dorsal hippocampus (AP 15.86 to 12.96 mm) were
analyzed entirely for BrdU-positive cells in the molecular layer, the
GCL, and the hilus. The subgranular zone, defined as a two-cell body-
wide zone along the border of the GCL and the hilus, always was
combined with the GCL for quantification. All BrdU-positive nuclei in
these selected areas were counted and presented as cells (in thousands)/
mm 3 (Table 2).
Cerebellum. On two sagittal sections of the cerebellum the fourth
lobulus was analyzed entirely for the density of BrdU-positive cells in the
molecular layer, GCL, and white matter. Cell numbers are expressed as
BrdU-positive cells (in thousands)/mm 3 (Table 2).
Statistical analysis was performed with one-way ANOVA, followed by
post hoc comparison with the Tukey post hoc test.
RESULTS
To study the effect of growth factors on the proliferation of adult
neural progenitor cells in vivo, we chronically infused EGF,
FGF-2, or aCSF for 2 weeks into the lateral ventricle of adult rats,
using osmotic minipumps. BrdU was administered intraperitone-
ally during the period of growth factor infusion to label dividing
cells. Animals either were killed on the last day of growth factor
infusion to analyze the mitotic effect of the growth factors or were
kept for an additional 4 weeks after terminating growth factor
infusion to study the differentiation of the newborn cells. Both
systems of adult neurogenesis, the SVZ/OB and dentate gyrus,
were analyzed for BrdU-positive cells. The cerebellum served as
a control area in the adult rat brain because it lacks detectable
neurogenesis. To quantify the proliferation of neural progenitor
cells and the survival of newborn cells after growth factor infu-
sion, we determined the density of BrdU-positive cells by stereo-
logical counting techniques. To characterize cell fate, we com-
bined BrdU labeling with the astroglial marker S100b, which
labels astrocytic cell bodies (Boyes et al., 1986), and the neuronal
marker NeuN, which recognizes neuronal cell bodies and nuclei
(Mullen et al., 1992). The percentage of BrdU-positive cells
colabeled either with NeuN or S100b was determined by triple
immunofluorescence and confocal laser scanning microscopy and
was multiplied by the overall density of BrdU-positive cells to
determine the density of newborn neurons and astrocytes.
EGF effects on proliferation and differentiation of
neural progenitors
Infusion of EGF induced a striking proliferation of the SVZ
precursor population. Expansion of BrdU-positive cells was most
pronounced in the lateral wall of the lateral ventricle (Fig. 2C). In
addition, newborn cells were found in the medial and posterior
circumference of the lateral ventricle, suggesting that progenitors
also were recruited to divide in “quiescent” areas of the SVZ.
Infusion of EGF resulted in “polyp-like” hyperplasias of the
ventricle wall, which consisted of BrdU-positive cells that were
immunonegative for either S100b or NeuN (Fig. 3). These EGF-
induced hyperplasias had regressed completely after 4 weeks
(Fig. 3C).
Quantification of the SVZ revealed a ninefold increase in the
density of newborn cells over aCSF controls immediately after
EGF infusion. The number of labeled cells present after 4 weeks
remained increased relative to controls (Fig. 2, Table 1). There
was also an increase in the number of labeled cells observed in
adjacent areas, particularly in the striatum (Fig. 4C, Table 1), but
also in cortex and septum (Fig. 4F,I), where the majority of
newborn cortical cells was detected around the cannula tract (Fig.
4F). Interestingly, in the striatum triple labeling of BrdU-positive
EGF-generated striatal cells with BrdU, NeuN, and S100b re-
Table 1. Density and cell fate of newborn cells in the subventricular zone, olfactory bulb, and striatum
Area aCSF FGF-2 EGF
Subventricular zone
1 d after infusion
Cannula side 62.2 6 9.8 208.5 6 62.2** 595.5 6 133.1**
Contralateral side 37.1 6 8.1 32.6 6 4.4 70.3 6 9.9**
4 weeks after infusion
Cannula side 30.6 6 10.7 104.8 6 27.7** 153.6 6 27.8**
Contralateral side 13.3 6 3.9 13.5 6 2.7 88.0 6 11.8**
Rostral migratory str.
1 d after infusion 915.5 6 50.0 714.4 6 38.0* 368.8 6 25.0**
Olfactory bulb
4 weeks after infusion
Total 40.9 6 2.0 (100) 46.9 6 1.2* (100) 16.3 6 1.6** (100)
Neurons 39.3 6 1.6 (96) 45.2 6 0.9* (96) 11.8 6 1.5** (72)
Astrocytes 0.16 6 0.11 (,0.1) 0.26 6 0.10 (,0.1) 2.26 6 0.54** (14)
Striatum
4 weeks after infusion
Total 2.8 6 0.4 (100) 6.1 6 0.8** (100) 12.3 6 3.5** (100)
Neurons 0 (0) 0 (0) 0 (0)
Astrocytes 0.2 6 0.1 (6) 1.4 6 0.4** (22) 4.5 6 1.4** (39)
BrdU1/satellite cells 1.1 6 0.1 (40) 3.2 6 0.5* (53) 5.2 6 1.1* (46)
BrdU1/sat./astrocytes 0.05 6 0.03 (1.8) 0.6 6 0.2* (10) 1.7 6 0.7* (14)
The brain areas were selected for unbiased quantification, as shown in Figure 1. Densities of newborn cells after aCSF, FGF-2, and EGF infusion are presented as the mean
number of BrdU-positive cells (in thousands) per mm3 6 SEM. *p , 0.05; **p , 0.01. To determine the cell type of BrdU-positive cells 4 weeks after infusion, we used NeuN
as a marker for neurons and S100b for astrocytes. Percentages of cell types (numbers in parentheses) are based on the total density of BrdU-positive cells.
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vealed no BrdU-labeled neurons. Although a large number of
BrdU-positive nuclei (45%) were associated closely with neurons,
three-dimensional confocal analysis revealed that the BrdU-
positive nuclei belonged to a cell body located in a different focal
plane (Fig. 5). These closely attached BrdU-positive cells fre-
quently colabeled (up to 30%) with S100b, suggesting that these
cells were satellite cells of glial origin. Because this finding stands
in contrast to a previous report of EGF-induced neurogenesis in
the adult mouse striatum (Craig et al., 1996), we reanalyzed the
sections from the striatum and cerebral cortex of each EGF-
treated animal (4 weeks after infusion) looking for cells that
appeared to be double-labeled for BrdU and NeuN. Detailed
confocal z-series analysis of 20 cells per animal revealed invari-
ably that none of the BrdU-positive nuclei was contained within
a NeuN-positive neuron. Thus, of a total of .2800 newborn cells
scored, none were neurons.
Many of the cells born in the SVZ migrate along the RMS into
the OB, where they differentiate into neurons (Corotto et al.,
1993; Lois and Alvarez-Buylla, 1993). On their way to the OB the
progenitor cells can undergo cell division as well as differentiation
into neuroblasts that express early neuronal markers like TuJ1
(Bonfanti and Theodosis, 1994; Thomas et al., 1996). Four weeks
after infusion no residual BrdU-positive cells could be detected in
the RMS (Fig. 6F). Although more cells are born in the SVZ in
response to EGF treatment, significantly fewer BrdU-positive
cells (40% of aCSF control) are present in the RMS (Fig. 6C,
Table 1). The number of newborn cells that reached the OB after
4 weeks of EGF infusion also was reduced significantly (40% of
the aCSF control, Table 1). PSA-NCAM, the polysialylated form
of the neural cell adhesion molecule, appears to be required for
migration of neuronal precursors within the RMS (Ono et al.,
1994; Hu et al., 1996). Although PSA-NCAM expression was not
quantified, it was detected by immunofluorescence labeling in all
experimental groups (Fig. 6A–C). Therefore, EGF-induced re-
duction of newborn SVZ cells in the RMS was not attributable to
the absence of PSA-NCAM after growth factor treatment. Triple
immunofluorescence showed that the population of newborn cells
that reached the GCL of the OB in control animals consisted of
;96% neurons and ,0.1% astrocytes, whereas EGF not only
reduced the number of cells reaching the bulb but also shifted the
ratio toward a glial lineage (72% neurons/14% astrocytes) (Fig. 7,
Table 1). The absolute density of newborn glia increased from 160
cells/mm3 in controls to 2260 cells/mm3 (14-fold) after EGF
treatment (Table 1). Therefore, the shift was not simply a relative
increase in newborn glia because of a decrease in newborn neu-
ronal cells but also indicated an increased de novo gliogenesis.
Within the hippocampus, cells born at the boundary between
the hilus and GCL migrate into the GCL before differentiating
into neurons. All three layers of the hippocampal dentate gyrus
(molecular layer, GCL, and hilus) were analyzed for the density
of newborn cells after EGF treatment. The molecular layer of
EGF-treated animals demonstrated a significant increase in the
number of BrdU-positive cells. The majority of these cells was
found in the immediate vicinity of the wall of the third ventricle.
In the hilus and GCL, where neurogenesis normally occurs, the
number of newborn cells was not altered significantly at the end of
EGF infusion or 4 weeks later (Table 2). In aCSF-treated animals
92% of the newborn cells differentiated into neurons and ,1%
into astrocytes. In contrast, EGF changed this ratio to 52%
neurons and 39% astrocytes (Fig. 8, Table 2), inducing a shift
toward the glial fate that was even more pronounced than in the
OB. The absolute density of newborn glia increased from 10
cells/mm3 in controls to 1130 cells/mm3 (.100-fold) after EGF
treatment (Table 1). Even more prominent than in the OB, the
shift toward glial differentiation was attributable to an increased
Table 2. Density and cell fate of newborn cells in the dentate gyrus and cerebellum
Area aCSF FGF-2 EGF
Dentate gyrus
1 d after infusion
Granule cell layer 5.60 6 0.49 4.87 6 1.06 7.77 6 1.10
Hilus 1.09 6 0.34 1.14 6 0.22 2.06 6 0.59
Molecular layer 0.66 6 0.11 0.92 6 0.17 3.69 6 0.32**
4 weeks after infusion
Granule cell layer
Total 3.44 6 0.56 (100) 3.25 6 0.32 (100) 2.84 6 0.89 (100)
Neurons 3.19 6 0.52 (93) 2.91 6 0.27 (90) 1.50 6 0.52** (53)
Astrocytes 0.01 6 0.01 (0.2) 0.01 6 0.01 (0.2) 1.13 6 0.35** (40)
Hilus 0.57 6 0.17 0.67 6 0.14 1.02 6 0.22
Molecular layer 0.62 6 0.07 0.70 6 0.10 2.32 6 0.47**
Cerebellum
1 d after infusion
Molecular layer 0.081 6 0.019 0.160 6 0.035 0.133 6 0.027
Granule cell layer 0.065 6 0.027 0.113 6 0.007 0.065 6 0.025
White matter 0.084 6 0.041 0.050 6 0.031 0.082 6 0.018
4 weeks after infusion
Molecular layer 0.069 6 0.008 0.073 6 0.016 0.094 6 0.009
Granule cell layer 0.079 6 0.007 0.084 6 0.021 0.123 6 0.017
White matter 0.079 6 0.012 0.095 6 0.028 0.152 6 0.027
The brain areas were quantified by unbiased sampling methods. Densities of newborn cells after aCSF, FGF-2, and EGF infusion are presented as the mean number of
BrdU-positive cells (in thousands) per mm3 6 SEM. **p , 0.01. To determine the cell type of BrdU-positive cells in the dentate gyrus 4 weeks after infusion, we used NeuN
as a marker for neurons and S100b for astrocytes. Percentages of cell types (numbers in parentheses) are based on the total density of BrdU-positive cells.
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de novo gliogenesis and not merely a relative increase because of
a decrease in newborn neuronal cells.
FGF-2 effects on proliferation and differentiation of
neural progenitors
The density of newborn cells in the SVZ was increased by FGF-2,
although to a lesser extent than by EGF, and the density of
newborn cells into the adjacent striatal parenchyma was increased
over aCSF controls (Figs. 2B, 4B, Table 1). None of the BrdU-
positive cells in the striatum of FGF-2-treated animals was
double-labeled for NeuN, although some newborn cells in the
striatum were juxtaposed closely to neuronal cell bodies, as seen
in EGF animals. FGF-2 also decreased the number of BrdU-
positive cells in the RMS at the end of infusion (Fig. 6B, Table 1).
As with EGF infusion and in aCSF controls, no BrdU-positive
cells were detectable in the RMS 4 weeks later (Fig. 6D–F).
However, in contrast to the EGF animals, the number of BrdU-
positive cells found in the GCL of the OB 4 weeks after FGF-2
infusion was increased significantly over controls (Table 1). This
general increase in the density of newborn olfactory cells was
accompanied by an increase of newborn neurons. The number of
newborn glial cells was not altered significantly, although this was
probably because of the infrequent detection of BrdU/S100b-
positive cells and a resulting high variance (Table 1).
In contrast to the SVZ/OB system, the generation of newborn
cells in the hippocampal dentate gyrus was not affected by FGF-2
treatment. The ratio between newborn neurons and astrocytes
also was not altered 4 weeks after FGF-2 treatment, indicating
that both proliferation and differentiation of hippocampal pro-
genitors were unaffected by the growth factor (Fig. 8, Table 2).
Analysis of newborn cells in the cerebellum revealed no signif-
icant changes at the end of growth factor treatment or 4 weeks
after withdrawal of either growth factor (Table 2), indicating that
this brain structure, which normally shows no adult neurogenesis,
is unresponsive to these growth factors.
DISCUSSION
During development, growth factors provide important extracel-
lular signals for regulating the proliferation and fate determina-
tion of stem and progenitor cells in the CNS (Calof, 1995). By
infusing EGF and FGF-2 into the lateral ventricle of adult rats,
we could show that the two populations of progenitors that
continue to divide in the adult brain respond differently to these
growth factors in vivo. Proliferation of hippocampal progenitors
was unaffected by either EGF or FGF-2. In contrast, proliferation
of subventricular progenitor cells increased after both FGF-2 and
EGF administration, with EGF having a more dramatic effect.
These findings are consistent with numerous in vitro studies that
have shown that both factors can maintain responsive neural
progenitors in cell cycle, thus expanding the progenitor popula-
tion and delaying differentiation (Richards et al., 1992; Vescovi et
al., 1993; Morshead et al., 1994; Sensenbrenner et al., 1994;
Bouvier and Mytilineou, 1995; Gage et al., 1995a; Gritti et al.,
1995, 1996; Palmer et al., 1995; Santa-Olalla and Covarrubias,
1995).
FGF-2 had a strong mitotic effect on the SVZ progenitors in
vivo, but the migration of newborn cells in the RMS was
diminished during the infusion period. However, 4 weeks after
FGF-2 infusion, a larger number of newly generated cells were
detected in the OB, indicating an increased migration of SVZ
progenitors after withdrawal of FGF-2. In vitro results suggest
that FGF-2 has the potential to keep uncommitted progenitors
in cell cycle and to delay differentiation (Vescovi et al., 1993;
Bouvier and Mytilineou, 1995; Kilpatrick and Bartlett, 1995;
Palmer et al., 1995; Gritti et al., 1996). The biphasic response
of RMS cells to FGF-2 could be attributable to increased
proliferation in the SVZ, which reduces progenitor cell migra-
tion through the stream. After FGF-2 withdrawal a larger
number of cells would be released into the RMS, generating
more newborn cells in the OB 4 weeks later. Because 96% of
the newborn olfactory cells differentiated into neurons, we
conclude that FGF-2 had a stimulatory effect on the generation
of OB neurons. However, because a very low number of new-
born glial cells were detected here, conclusions about FGF-2-
induced changes of the glial cell population in the OB are not
possible. EGF infusion also expanded the SVZ precursor pop-
ulation while decreasing the number of newborn cells in the
RMS. However, in contrast to FGF-2, EGF withdrawal re-
duced neurogenesis in the OB, whereas the genesis of astro-
cytes was stimulated. Although olfactory neurogenesis in-
volves separate areas for cell division (SVZ), migration
(RMS), and differentiation (OB), recent studies have shown
that cell division and neuronal commitment of progenitor cells
can occur in the migratory stream (Bonfanti and Theodosis,
1994; Menezes et al., 1995; Lois et al., 1996; Thomas et al.,
1996). Astrocytes in the RMS are typically neither proliferat-
ing nor participating in the migration (Lois and Alvarez-
Buylla, 1994; Lois et al., 1996). We assume that EGF acts on
proliferation primarily in the SVZ and on differentiation pri-
marily in the OB but also is influencing cells in the RMS.
Progenitor populations in SVZ and hippocampus were affected
differently by EGF. EGF had no proliferative effect on hippocam-
pal progenitors, whereas even progenitors in quiescent areas of
the SVZ, such as the medial and posterior regions of the ventric-
ular wall, were recruited by EGF to enter the cell cycle. Normally,
3
Figure 2. BrdU-positive cells in the SVZ at the end of and 4 weeks after intracerebroventricular infusion of aCSF (A, D), FGF-2 (B, E), and EGF (C,
F ). Note the large expansion of the SVZ and the density of newborn cells in the striatum after FGF-2 administration ( B), which are even more dramatic
after EGF administration (C). Proliferation was more pronounced on the side of the cannula, as compared with the contralateral side. Four weeks after
growth factor withdrawal, a high density of BrdU-positive cells was still present in the SVZ of EGF-treated animals (F). Scale bar in A, 50 mm.
Figure 3. “Polyp-like” hyperplasia in the SVZ of EGF-treated animals at the end of treatment (2 weeks). A, High density of BrdU-positive cells at the
convex pole of a hyperplasia, which protrudes into the CSF-filled ventricle. B, BrdU-positive cells are immunonegative for neuronal (NeuN, red) and
astrocytic markers (S100b, blue). The ependymal layer (S100b, blue) is discontinuous (arrows) in areas of growth. C, Density of BrdU-labeled cells is
still increased; however, the hyperplastic changes completely regress 4 weeks after EGF withdrawal. Scale bars in A, C, 25 mm.
Figure 4. Increased number of BrdU-positive cells in the striatum ( A–C), cortex ( D–F), and medial septum ( G–I) of EGF- and FGF-2-treated animals
at the end of infusion. D–F, Note the increase of BrdU-positive cells along the cannula tract in the cerebral cortex (on the lef t side of the images). Shown
are confocal microscopic images with immunofluorescent triple labeling for BrdU ( green), NeuN (red), and S100b (blue). Scale bar in A, 200 mm.
5824 J. Neurosci., August 1, 1997, 17(15):5820–5829 Kuhn et al. • EGF and FGF-2 Effects on Adult Neural Progenitors In Vivo
Kuhn et al. • EGF and FGF-2 Effects on Adult Neural Progenitors In Vivo J. Neurosci., August 1, 1997, 17(15):5820–5829 5825
5826 J. Neurosci., August 1, 1997, 17(15):5820–5829 Kuhn et al. • EGF and FGF-2 Effects on Adult Neural Progenitors In Vivo
the majority of precursor cells from the SVZ and hippocampus
differentiates into neurons in their appropriate target regions
(Kaplan and Hinds, 1977; Bayer, 1983; Cameron et al., 1993).
However, in animals treated with EGF, the ratio of newborn
neurons to astrocytes was altered, favoring glial differentiation.
Among others, three alternative underlying cellular mechanisms
are possible. (1) EGF could have opposite effects on separate glial
and neuronal precursor populations, thus inducing proliferation
of glial and reducing proliferation of neuronal progenitors. (2)
Another explanation involves the effect of cell death on changes
in progenitor populations. Developmental studies have shown
direct evidence (Gould et al., 1991; Naruse and Keino, 1995;
Blaschke et al., 1996) and studies of adult neurogenesis have
shown indirect evidence (Morshead and van der Kooy, 1992) that
naturally occurring cell death might play an important role in
controlling the number of neuronal progenitors from SVZ and
hippocampus. Therefore, general stimulation of proliferation by
EGF in combination with increased cell death of neuronal pro-
genitors could produce an increase in newborn glial cells without
having a specific stimulatory effect of glial progenitors. The data
from SVZ/OB could be interpreted in this way, because the
increase in SVZ proliferation is equivalent to the increase in
newborn OB glia. However, in the hippocampus the .100-fold
increase in gliogenesis is not matched by a significantly higher
proliferation. (3) The recent finding that multipotent neural stem
cells exist in the adult rodent brain (Kilpatrick and Bartlett, 1993;
Lois and Alvarez-Buylla, 1993; Morshead et al., 1994; Gage et al.,
1995b; Palmer et al., 1995; Gritti et al., 1996; Reynolds and Weiss,
1996; Svendsen et al., 1996) suggests that EGF infusion could
stimulate proliferation of stem cells in the brain but also could
influence the fate of these multipotent cells toward a glial lineage.
The limited effect of FGF-2 on hippocampal progenitors in vivo
contrasts with previous reports of the ability of FGF to maintain
proliferative hippocampal progenitors in vitro (Ray et al., 1993;
Gage et al., 1995a). It may be possible that hippocampal progen-
itors in their natural environment are not responsive to exoge-
nous FGF-2 in the dose provided in this study. Alternatively, low
penetration efficiency might reduce the availability of FGF-2 in
the brain parenchyma (Gonzalez et al., 1994). Improved penetra-
tion could be achieved by addition of soluble FGF-binding mol-
ecules, such as heparan sulfate proteoglycans, to the infusion
solution to prevent rapid absorption of FGF-2 by extracellular
matrix molecules during infusion (Rapraeger et al., 1994).
Our findings are in part consistent with and in part in contrast
to a recent study in adult mice (Craig et al., 1996). As in our study,
EGF induced an expansion of the SVZ and an increased density
of newborn cells into the adjacent striatum, cortex, and septum
(Fig. 4). Whether the newborn cells migrated into these areas or
were stimulated locally cannot be decided from our data, because
multiple BrdU injections prevent the exact determination of birth
place and time for these cells. However, in contrast to our
findings, immunofluorescent double labeling of striatal and cor-
tical cells with NeuN and BrdU in the previous study in mice
(Craig et al., 1996) had indicated that newborn cells showed a
neuronal phenotype. In our study three-dimensional confocal
analysis revealed that NeuN and BrdU invariably were detected
in separate cells (Fig. 5). A portion of the BrdU-positive cells that
were juxtaposed to the NeuN-immunoreactive neurons expressed
S100b, indicating that they were of astrocytic origin. Perineuronal
satellite cells were described as early as 1913 by Ramo´n y Cajal as
being positioned closely to neuronal perikarya and being of as-
trocytic and oligodendrocytic origin (Penfield, 1932; Ludwin,
1979, 1984). However, not all of the closely juxtaposed cells were
S100b-positive, so we cannot exclude the possibility that some of
the “unclassified” cells are uncommitted progenitor cells, which
may differentiate into neurons at a later time point. In summary,
although some experimental conditions, such as continuous EGF
infusion, daily EGF doses, and immunohistochemical markers
(BrdU, NeuN, and S100b), were comparable between the two
studies, species differences (rat vs mouse) and, in particular,
different histological analyses may account for the discrepancies.
A surprising finding of chronic EGF stimulation was the induc-
tion of pronounced hyperplasias in the ventricular wall, which
protruded into the CSF-filled space (Fig. 3). Although receptors
for both EGF and FGF-2 are expressed by subependymal cells
(Gonzalez et al., 1995; Weickert and Blum, 1995; Craig et al.,
1996), only EGF induced this hyperplasia. Numerous studies have
shown the involvement of the EGF receptor family in tumorogen-
esis of the CNS (for review, see Berger et al., 1992; Collins, 1995;
von Deimling et al., 1995). Four weeks after treatment the EGF-
induced hyperplasia regressed completely, indicating that the con-
tinuous presence of EGF was required for the abnormal growth.
4
Figure 5. Close association of neurons with newborn cells (satellite cells). A, A NeuN-positive neuron (red and black/white inset) appeared to be
colabeled with BrdU in a merged image resembling a regular fluorescent microscope image. B–H, Z-series analysis revealed that the NeuN-positive
neuronal cell body is situated in a different focal plane from the BrdU-positive nucleus. Note that the NeuN-positive nucleus with nucleolus is visible
in C and the BrdU-positive nucleus in E and F. Scale bar in A, 10 mm.
Figure 6. Reduced rostral migration of BrdU-positive cells at the end of EGF and FGF-2 infusions. Compared with aCSF controls (A), the number
of BrdU-positive cells ( green) in the RMS is decreased in FGF-2 (B) and decreased further in EGF-treated animals (C). However, PSA-NCAM (red),
which is required for migration of progenitors within the RMS, is present in all groups. No BrdU-positive cells can be found at 4 weeks after infusion
(D–F ). Images D–F are immunofluorescent double labelings for BrdU ( green) and S100b (blue). Note that scanning parameters for the confocal
microscope are identical for A–F. Scale bar in A, 50 mm.
Figure 7. Cellular phenotype of newborn cells in the olfactory bulb. Cells in the olfactory granule cell layer were characterized at 4 weeks after infusion
of aCSF (A), FGF-2 (B), or EGF (C) for BrdU ( green), NeuN (red), and S100b (blue). After aCSF or FGF-2 treatment the vast majority of newborn
cells double labels for NeuN ( green/red). Note the reduced number of BrdU-positive cells that reach the olfactory bulb in EGF-treated animals (C; see
also Table 1). The differentiation of EGF-induced progenitors was shifted toward a glial lineage. Arrows indicate newborn astrocytes ( green/blue). Scale
bar in A, 20 mm.
Figure 8. Cellular phenotype of newborn cells in the dentate gyrus. Cells in the hippocampal granule cell layer were characterized at 4 weeks after
infusion of aCSF (A), FGF-2 (B), or EGF (C) for BrdU ( green), NeuN (red), and S100b (blue). After aCSF or FGF-2 treatment the vast majority of
newborn cells double labels for NeuN ( green/red). The differentiation of EGF-induced progenitors has shifted toward a glial lineage (C). Arrow indicates
a newborn astrocyte ( green/blue). Scale bar in A, 20 mm.
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In vitro models have been excellent tools for analyzing signals
that influence the proliferation and fate of neural progenitor cells,
but it has been difficult to determine how well these in vitro
observations relate to signaling in vivo. By testing mitogens
known to be effective in vitro, we have been able to show that
progenitor populations in the adult rodent brain respond, in part,
differently from in vitro. The site-specific responsiveness of pro-
genitors to exogenous factors indicates that local cues play an
important role in regulating neurogenesis in vivo. In the absence
of in vivo signals, progenitors cultured in the presence of EGF
proliferate and differentiate into neurons and glia, yet, in vivo,
EGF has a stimulatory influence on proliferation and the genesis
of glia but an unexpected limiting effect on the generation of
neurons. This dichotomy emphasizes the importance of obtaining
in vivo and in vitro results to identify more completely the factors
that direct site-specific neuronal differentiation.
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